AECOPD
Conditions
Interventions
Control group :? Continuous low flow oxygen (1-3L/min) was given
? Budesonide suspension for inhalation 1mg+ compound ipratropium bromide solution for inhalation 2.5ml nebulized to relieve spasmodic asthma, bid
? Initial empirical treatment according to the common pathogens of clinical experience, blood (sputum) culture and drug sensitivity test should be collected, and antibiotics should be adjusted accordi
treatment group:The more oral menservants and Yue maideng and Banxia decoction
Sponsors
Panyu Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 85 Years
Inclusion criteria
Inclusion criteria: ? In accordance with the diagnostic criteria of western medicine AECOPD, the severity of lung function was classified as ?-?, and in accordance with the diagnostic criteria of TCM phlegm-heat obstructing the lung syndrome (including newly diagnosed or previously diagnosed COPD patients); ? age between the age of 40 to 85 (including boundary value), no sex; ? voluntarily participated in the study and signed the informed consent.
Exclusion criteria
Exclusion criteria: ? Pregnant and lactating women; ? Acute respiratory failure requiring invasive mechanical ventilation; ? refusing to sign the informed consent form with poor compliance; ? those who were allergic to any component of the conventional treatment drugs or Yuemei Jiabanxia decoction during the trial; ? combined with bronchial asthma, pulmonary tuberculosis and other serious underlying diseases; ? and patients who did not meet the above inclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective rate;Interleukin-6; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM symptom score;White cell count;C - reactive protein;Tumor necrosis factor;PaO2;PaCO2;advanced glycosylation end products,AGEs;Solublereceptor for advanced glycationend,sRAGE; | — |
Countries
China
Contacts
Public ContactSheng Luo
Panyu Hospital of Traditional Chinese Medicine
Outcome results
None listed